These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33958523)

  • 21. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
    Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
    Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiparameter digital image analysis of biliary, ampullary, and pancreatic adenocarcinomas.
    Yeaton P; Kiss R; DePrez C; Salmon I; Pasteels JL; Jones RS; Frierson HF
    Mod Pathol; 1995 Oct; 8(8):843-7. PubMed ID: 8552573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
    Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas.
    Jeong BK; Sung YN; Kim SJ; An S; Park H; Hwang HS; Kang HJ; Lee JH; Song KB; Kim KP; Hwang DW; Lee SS; Kim SC; Hong SM
    Hum Pathol; 2019 Feb; 84():92-104. PubMed ID: 30261192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma.
    Abouelkhair MB; Mabrouk SH; Zaki SSA; Nada OH; Hakim SA
    J Gastrointest Cancer; 2021 Sep; 52(3):960-969. PubMed ID: 32929682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
    Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
    Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LI-cadherin and CDX2: Useful Markers in Metastatic Gastrointestinal Adenocarcinoma Cells in Serous Cavity Effusion.
    Ma H; Yu J; Tang J
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):e75-e80. PubMed ID: 30095466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
    Xiao W; Hong H; Awadallah A; Zhou L; Xin W
    PLoS One; 2014; 9(1):e86853. PubMed ID: 24489794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy.
    Maeda K; Uehara T; Hosoda W; Kuraishi Y; Ota H
    Pathol Res Pract; 2024 Oct; 262():155537. PubMed ID: 39178509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
    Dhakhwa R; Kafle N
    JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
    Hornick JL; Lauwers GY; Odze RD
    Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
    Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.